- OT
- 100% Optical: Previous shows
- Education at 100% Optical: Glaucoma
100% Optical
Education at 100% Optical: Glaucoma
OT dives into a key topic in the education programme at 100% Optical 2026. This week: Sana Hamid shares insight into her lecture on ROCK inhibitors and OT rounds up key sessions on collaboration in glaucoma care
06 January 2026
Glaucoma, myopia, optical coherence tomography, practising safely and wellbeing are all key themes that have emerged through the 100% Optical 2026 education programme.
The show, held at Excel London from 28 February–2 March, will feature a comprehensive programme of education for optical professionals to enhance their knowledge, consolidate skills, and discover evolving areas of research.
OT has highlighted a handful of sessions exploring the topic of glaucoma.
Education expert: Dr Byki Huntjens, education lead at the AOP, on glaucoma-focused sessions
Glaucoma is a silent, progressive condition that remains one of the biggest threats to vision in the UK and globally. With earlier detection, enhanced imaging tools, and shared care models, optometrists are playing an increasingly critical role in identifying and monitoring at-risk patients. As hospital services become stretched, community-based glaucoma management will only grow in importance.
This year’s 100% Optical programme will help you enhance your diagnostic confidence, understand current referral thresholds, and explore how artificial intelligence and wider inter-professional collaboration are shaping the future of glaucoma care. A must for any eye care professional looking to stay ahead of the curve.
Lecture: The role of ROCK inhibitors in glaucoma care

Sana Hamid, a consultant ophthalmic surgeon at Moorfields Eye Hospital NHS Foundation Trust, will lead a Main Stage session on Saturday 28 February at 10.30am.
The lecture will review the pharmacological basis of Rho-kinase (ROCK) inhibition, summarising clinical trial data, and considerations for prescribing.
Hamid told OT: “I hope delegates leave with a clear understanding of how ROCK inhibitors work, their efficacy and side effect profile, and where they fit within current glaucoma treatment pathways, particularly in light of the new NICE guidelines.”
“The lecture aims to translate the science and evidence into practical application, helping clinicians recognise which patients may benefit most and when to consider introducing ROCK inhibitors in practice so they feel confident offering this new therapeutic option to improve patient outcomes,” she shared.
Lecture: Eye health for all – tackling glaucoma together
Taking to the Main Stage at 9.15am on Sunday 1 March, Robyn Asprey, development manager (outreach services) at Glaucoma UK, will present the charity's co-produced outreach work with African and Caribbean communities to raise awareness of glaucoma and promote early detection.
The session will outline how relationships were formed with community groups and organisations, and how partnerships with optometrists helped address barriers to accessing eye care.
Lecture with discussion workshop: The yellow brick road to glaucoma higher qualifications

Bhavik Parmar, head of CPD at Specsavers, will present this session on both Saturday 28 February and Sunday 1 March on the Specsavers’ stand.
Parmar told OT: “The session is designed to provide delegates with a clear understanding of how further glaucoma qualifications boost clinical confidence, broaden their scope of practice and improve patient outcomes. By exploring case studies, I’ll show how advanced training supports evidence-based decisions and enables more personalised care and safe management of patients with, or at risk of, glaucoma.”
He added: “The session is also designed to increase understanding about the value of working collaboratively across primary and secondary care. I also hope attendees feel empowered to tailor patient management to individual patient needs, while applying the latest research and guidance.”
Lecture: Diagnostic challenges, advancements, and future directions of glaucoma
This Main Stage session on Monday 2 March at 3.30pm will be led by Sayantan Biswas, lecturer at Aston University.
In the lecture, Biswas will revisit the definition of pathophysiology of glaucoma, highlighting clinical challenges in primary and secondary care, as well as advances in diagnostic imaging, risk assessment, and monitoring.
The session is also set to consider the future for glaucoma detection with emerging technologies and pathways.
Visit the education programme to find more sessions dedicated to this topic, and more.
Comments (0)
You must be logged in to join the discussion. Log in